10.3390/antiox14091033 38 GuerraC.MorrisD.SipinA.KungS.FranklinM.GrayD.et al (2011)
We dissect how these rationally engineered platforms overcome the unique physical and cellular barriers of the osteosarcoma TME, with a critical emphasis on the severe translational hurdles, such as protein corona formation and in vivo stability, that limit clinical progression
Roll, do not shake: Gently roll the vial between your palms until fully dissolved
Your journey is so incredible
That said, informed patients who know what to expect tolerate the protocol far better than those who encounter side effects without context
doi: 10.3389/fneur.2024.1356662 Received 15 December 2023 Accepted 10 May 2024 Published 19 June 2024 Volume 15 - 2024 Edited by Dominic D'Agostino, University of South Florida, United States Reviewed by Anandakumar Shunmugavel, Case Western Reserve University, United States Xuehua Liu, Capital Medical University, China Updates Copyright 2024 Fogarty and Harch